Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Cracking the Code: What DTCs Tell Us About Vehicle Repair Trends
Diagnostic scanning has become a critical first—and last—step in the repair process. While mechanics have long relied on it to identify emission system malfunctions, collision repairers are now more routinely performing pre- and post-scans.
At the eye of the storm: An opioid overdose epidemic and a viral pandemic converge
s 2020 opened, a persistent and tragic opioid overdose epidemic was near the front of a list of national concerns in the US. Some 20+ million Americans are reported to have a substance use disorder and 2M of those misuse opioids.
Is Your Workplace Safe2Work?
As employers are looking for efficient ways to keep work environments safe from COVID-19, Optis has developed Safe2Work, an app-enabled, web-based
Quality Control in Clinical, Interview with Sharon Riley
We interviewed Sharon Riley, Director of Service Operations for Field Case Management, Coventry about best practices for quality assurance within a clinical case management program. Read on for her insightful responses.
Opioid Risk Mitigation: Medication-Assisted Treatment (MAT) and Naloxone
This week in our in-depth review of our Coventry Drug Trends series, part three, we focus on opioid risk mitigation strategies. While opioids continue to decline in workers’ compensation as both a percentage of total script volume and costs, it remains vital to promote evidence-based strategies such as MAT and naloxone to curb opioid issues.
Risk & Insurance: 10 Workers' Comp Podcasts You Really Don't Want to Miss
When it comes to learning about the workers' compensation industry, there is a plethora of resources already at your fingertips.